Halozyme Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
04.12.25
/
50%
€53.66
Target price
04.12.26
€48.01
Performance (%)
3.95%
Price
24.04.26
€55.78
Summary
This prediction is currently active. With a performance of 3.95%, the SELL prediction by The_Goldman_Sachs_Gr for Halozyme Therapeutics Inc. is trending in the wrong direction This prediction currently runs until 04.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | -5.265% | -5.265% |
| iShares Core DAX® | -1,74 % | 5,98 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % |
| iShares S&P 500 | 0,97 % | 7,62 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $56.00 price target on the stock.
Ratings data for HALO provided by MarketBeat